BioNTech and Crescendo Biologics team up to develop multi-specific precision immunotherapies

BioNTech and Crescendo, a clinical stage immuno-oncology company developing targeted T cell enhancing therapeutics, have entered a multi-target discovery collaboration to develop novel immunotherapies for cancer and other diseases.